Johnson & Johnson Co. is a
prestigious company university
established in 1886 in United States. It is represented
by 509 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Medical and Health Sciences (184 scientists), Natural Sciences (101 scientists), and Engineering & Technology (44 scientists).
* Total H Index Rankings
Ranking Based
On Selection :1
Drug transporters
Drug-Drug Interactions
Enzyme Induction
Drug-Induced Liver Injury
ADME
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
31
0.574
* Total H Index Rankings
Ranking Based
On Selection :2
pharmacokinetics/pharmacodynamics
drug-drug interaction
MIDD
QSP
clinical pharmacology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
27
0.659
* Total H Index Rankings
Ranking Based
On Selection :3
Clinical Pharmacology
Pharmaceutics
Drug Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
38
19
0.500
* Total H Index Rankings
Ranking Based
On Selection :4
Clinical Pharmacology
Pharmacometrics
Drug Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
36
20
0.556
* Total H Index Rankings
Ranking Based
On Selection :5
clinical pharmacology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
35
18
0.514
* Total H Index Rankings
Ranking Based
On Selection :6
drug development
PK/PD model
QSP
clinical pharmacology
therapeutic biologics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
34
25
0.735
* Total H Index Rankings
Ranking Based
On Selection :7
Drug Discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
16
0.500
* Total H Index Rankings
Ranking Based
On Selection :8
CAR-T
Cell Therapy
Gene Editing
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
15
0.500
* Total H Index Rankings
Ranking Based
On Selection :9
Pharmaceutical Sciences
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
27
0.931
* Total H Index Rankings
Ranking Based
On Selection :10
Gene Therapy and Gene Delivery
Drug Discovery
T-cell Engagers
Immuno-Oncology
Protein Engineering
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
21
0.724
* Total H Index Rankings
Ranking Based
On Selection :11
Early development clinical trial design
Biomarkers
Statistical bio-informatics
omics data analysis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
28
18
0.643
* Total H Index Rankings
Ranking Based
On Selection :12
cardiovascular
metabolic disease
RWE
digital health
thrombosis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
28
15
0.536
* Total H Index Rankings
Ranking Based
On Selection :13
Cancer Research
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
22
0.815
* Total H Index Rankings
Ranking Based
On Selection :14
statistical genetics
precision medicine
fibrosis
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
21
0.778
* Total H Index Rankings
Ranking Based
On Selection :15
Clinical Pharmacology & Pharmacometrics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
19
0.704
* Total H Index Rankings
Ranking Based
On Selection :16
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
19
0.704
* Total H Index Rankings
Ranking Based
On Selection :17
cardiovascular biology
endothelial function
pulmonary vascular remodeling
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
19
0.704
* Total H Index Rankings
Ranking Based
On Selection :18
health economics
epidemiology
real world evidence
outcomes research
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
13
0.481
* Total H Index Rankings
Ranking Based
On Selection :19
Autologous CAR-T
iPSC CAR-T & CAR-NK
Tumor microenvironment
Cell-based Therapy
TIL & TCR Therapy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
24
0.960
* Total H Index Rankings
Ranking Based
On Selection :20
Viral metagenomics
viral discovery
biomarkers
RNA viruses
single-cell RNA-seq
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
22
0.917
* Total H Index Rankings
Ranking Based
On Selection :21
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
21
0.875
* Total H Index Rankings
Ranking Based
On Selection :22
Protiomics
Post translational modification
Drug discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
19
0.792
* Total H Index Rankings
Ranking Based
On Selection :23
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
13
0.542
* Total H Index Rankings
Ranking Based
On Selection :24
Pharmacokinetics
Drug Metabolism
PK PD
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
21
0.913
* Total H Index Rankings
Ranking Based
On Selection :25
Inflammatory Bowel Disease
Celiac Disease
Autoimmune Disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
20
0.870
Raymond Evers
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
31
0.574
Drug transporters
Drug-Drug Interactions
Enzyme Induction
Drug-Induced Liver Injury
ADME
Honghui Zhou
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
41
27
0.659
pharmacokinetics/pharmacodynamics
drug-drug interaction
MIDD
QSP
clinical pharmacology
Amarnath Sharma
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
38
19
0.500
Clinical Pharmacology
Pharmaceutics
Drug Development
Juan Jose Perez Ruixo|JJ Perez-Ruixo, JJP Ruixo
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
36
20
0.556
Clinical Pharmacology
Pharmacometrics
Drug Development
İtalo Poggesi
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
35
18
0.514
Weirong Wang
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
34
25
0.735
drug development
PK/PD model
QSP
clinical pharmacology
therapeutic biologics
Gunaretnam Rajagopal
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
32
16
0.500
John Lee
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
15
0.500
CAR-T
Cell Therapy
Gene Editing
Yue Guo
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
27
0.931
Pharmaceutical Sciences
Justin Scheer
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
29
21
0.724
Gene Therapy and Gene Delivery
Drug Discovery
T-cell Engagers
Immuno-Oncology
Protein Engineering
Willem Talloen
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
28
18
0.643
Early development clinical trial design
Biomarkers
Statistical bio-informatics
omics data analysis
Tc Sarich
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
28
15
0.536
cardiovascular
metabolic disease
RWE
digital health
thrombosis
Michela Capello
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
22
0.815
Bevan Emma Huang
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
21
0.778
statistical genetics
precision medicine
fibrosis
oncology
Mahesh N Samtani
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
19
0.704
Clinical Pharmacology & Pharmacometrics
Ivo Cornelissen
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
19
0.704
Lai-Ming Yung
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
19
0.704
cardiovascular biology
endothelial function
pulmonary vascular remodeling
Shane Kavanagh
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
13
0.481
health economics
epidemiology
real world evidence
outcomes research
Madhusudhanan Sukumar
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
24
0.960
Autologous CAR-T
iPSC CAR-T & CAR-NK
Tumor microenvironment
Cell-based Therapy
TIL & TCR Therapy
Nádia Conceição-Neto
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
22
0.917
Viral metagenomics
viral discovery
biomarkers
RNA viruses
single-cell RNA-seq
Wim Van Der Elst
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
21
0.875
Weixuan Chen
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
19
0.792
Protiomics
Post translational modification
Drug discovery
Jamese Hilliard
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
24
13
0.542
Ranjeet Dash
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
21
0.913
Pharmacokinetics
Drug Metabolism
PK PD
Galeb Abu-Ali
Johnson & Johnson Co.
New Jersey, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
20
0.870
Inflammatory Bowel Disease
Celiac Disease
Autoimmune Disease